Cancer-associated thromboembolism: could direct-acting oral anticoagulants be a promising therapeutic option? Literature review

Cancer-associated thromboembolism (CAT) is usually managed with low-molecular-weight heparins (LMWHs) or vitamin K antagonists (VKAs). The recent data suggest that direct-acting oral anticoagulants (DOACs) might have a role in the management of CAT both in terms of prevention and treatment. The aim...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkki:	Savvari Paraskevi
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Sciendo 2020-09-01
Ráidu:	Forum of Clinical Oncology
Fáttát:	cancer venous thromboembolic event cat direct oral anticoagulant drugs doacs
Liŋkkat:	https://doi.org/10.2478/fco-2019-0009
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!